{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T16:46:06Z","timestamp":1777653966103,"version":"3.51.4"},"reference-count":86,"publisher":"Public Library of Science (PLoS)","issue":"9","license":[{"start":{"date-parts":[[2014,9,29]],"date-time":"2014-09-29T00:00:00Z","timestamp":1411948800000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"DOI":"10.1371\/journal.pone.0107596","type":"journal-article","created":{"date-parts":[[2014,9,29]],"date-time":"2014-09-29T19:02:04Z","timestamp":1412017324000},"page":"e107596","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":106,"title":["Withaferin A Alone and in Combination with Cisplatin Suppresses Growth and Metastasis of Ovarian Cancer by Targeting Putative Cancer Stem Cells"],"prefix":"10.1371","volume":"9","author":[{"given":"Sham S.","family":"Kakar","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mariusz Z.","family":"Ratajczak","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Karen S.","family":"Powell","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mana","family":"Moghadamfalahi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Donald M.","family":"Miller","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Surinder K.","family":"Batra","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sanjay K.","family":"Singh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"340","published-online":{"date-parts":[[2014,9,29]]},"reference":[{"key":"ref1","first-page":"11","article-title":"Cancer statistics","volume":"63","author":"R Siegel","year":"2013","journal-title":"CA Cancer J Clin"},{"key":"ref2","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1097\/GRF.0b013e31824b4611","article-title":"Ovarian cancer: etiology, risk factors, and epidemiology","volume":"55","author":"J Hunn","year":"2012","journal-title":"Clin Obstet Gynecol"},{"key":"ref3","unstructured":"National Comprehensive Cancer Network. NCCN Clinical Practice Guidelines in Oncology. Ovarian Cancer. Version 1.2013. Available: <ext-link xmlns:xlink=\"http:\/\/www.w3.org\/1999\/xlink\" ext-link-type=\"uri\" xlink:href=\"http:\/\/HTTP:\/\/www.nccn.org\/professionals\/physician_gls\/pdf\/ovarian.pdf\" xlink:type=\"simple\">HTTP:\/\/www.nccn.org\/professionals\/physician_gls\/pdf\/ovarian.pdf<\/ext-link>"},{"key":"ref4","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1111\/j.1525-1438.2003.13357.x","article-title":"Long- term follow-up confirms a survival advantage of the paclitaxel-cisplatin regimen over the cyclophosphamide-cisplatin combination in advanced ovarian cancer","volume":"13","author":"MJ Piccart","year":"2003","journal-title":"Int J Gynecol Cancer"},{"key":"ref5","doi-asserted-by":"crossref","first-page":"1339","DOI":"10.1517\/13543784.2010.515585","article-title":"Overcoming platinum resistance in ovarian carcinoma","volume":"19","author":"K Matsuo","year":"2010","journal-title":"Expert Opin Investig Drugs"},{"key":"ref6","doi-asserted-by":"crossref","first-page":"1869","DOI":"10.1038\/onc.2011.384","article-title":"Molecular mechanisms of cisplatin resistance","volume":"31","author":"L Galluzzi","year":"2012","journal-title":"Oncogene"},{"key":"ref7","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1016\/j.ejphar.2010.09.085","article-title":"Cisplatin-induced cardiotoxicity: Mechanisms and cardioprotective strategies","volume":"650","author":"SE El-Awady","year":"2011","journal-title":"Eur J Pharmacol"},{"key":"ref8","doi-asserted-by":"crossref","first-page":"19","DOI":"10.2165\/00002018-200124010-00003","article-title":"Anticancer drug-induced kidney disorders","volume":"24(1)","author":"PE Kintzel","year":"2001","journal-title":"Drug Saf"},{"key":"ref9","first-page":"F700","article-title":"Mechanisms of death induced by cisplatin in proximal tubular epithelial cells: apoptosis vs. necrosis","volume":"270","author":"W Lieberthal","year":"1996","journal-title":"Am J Physiol"},{"key":"ref10","doi-asserted-by":"crossref","first-page":"819","DOI":"10.1016\/j.bbrc.2012.06.047","article-title":"Synergistic cytotoxic action of cisplatin and withaferin A on ovarian cancer cell lines","volume":"423","author":"SS Kakar","year":"2012","journal-title":"Biochem Biophys Res Commun"},{"key":"ref11","first-page":"932","article-title":"Inhibition of immunologically induced inflammation by the plant steroid withaferin A","volume":"23","author":"A Fugner","year":"1973","journal-title":"Arzneimittelforschung"},{"key":"ref12","doi-asserted-by":"crossref","first-page":"406","DOI":"10.1016\/j.vph.2006.01.015","article-title":"Immunomodulatory role of Withania somnifera root powder on experimental induced inflammation: An in vivo and in vitro study","volume":"44","author":"M Rasool","year":"2006","journal-title":"Vascul Pharmacol"},{"key":"ref13","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/S0378-8741(00)00213-0","article-title":"Review on some plants of Indian traditional medicine with antioxidant activity","volume":"71","author":"P Scartezzini","year":"2000","journal-title":"J Ethnopharmacol"},{"key":"ref14","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1023\/B:MCBI.0000026051.16803.03","article-title":"Cardioprotection from ischemia and reperfusion injury by Withania somnifera: a hemodynamic, biochemical and histopathological assessment","volume":"260","author":"SK Gupta","year":"2004","journal-title":"Mol Cell Biochem"},{"key":"ref15","doi-asserted-by":"crossref","first-page":"7661","DOI":"10.1158\/0008-5472.CAN-08-1510","article-title":"Withaferin A causes FOXO3a- and Bim-dependent apoptosis and inhibits growth of human breast cancer cells in vivo","volume":"68","author":"SD Stan","year":"2008","journal-title":"Cancer Res"},{"key":"ref16","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1007\/s10456-004-1026-3","article-title":"Withaferin A is a potent inhibitor of angiogenesis","volume":"7","author":"R Mohan","year":"2004","journal-title":"Angiogenesis"},{"key":"ref17","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1158\/0008-5472.CAN-06-2430","article-title":"Par-4-dependent apoptosis by the dietary compound withaferin A in prostate cancer cells","volume":"67","author":"S Srinivasan","year":"2007","journal-title":"Cancer Res"},{"key":"ref18","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1080\/01635580802381477","article-title":"Ayurvedic medicine constituent withaferin a causes G2 and M phase cell cycle arrest in human breast cancer cells","volume":"60","author":"SD Stan","year":"2008","journal-title":"Nutr Cancer"},{"key":"ref19","doi-asserted-by":"crossref","first-page":"1697","DOI":"10.1093\/carcin\/bgr192","article-title":"Withaferin A induces p53-dependent apoptosis by repression of HPV oncogenes and upregulation of tumor suppressor proteins in human cervical cancer cells","volume":"32","author":"R Munagala","year":"2011","journal-title":"Carcinogenesis"},{"key":"ref20","doi-asserted-by":"crossref","first-page":"542","DOI":"10.1016\/j.bcp.2009.09.017","article-title":"Withaferin A targets heat shock protein 90 in pancreatic cancer cells","volume":"79","author":"Y Yu","year":"2010","journal-title":"Biochem Pharmacol"},{"key":"ref21","doi-asserted-by":"crossref","first-page":"1014","DOI":"10.1007\/s10495-011-0625-x","article-title":"Withaferin A induces apoptosis in human melanoma cells through generation of reactive oxygen species and down-regulation of Bcl-2","volume":"16","author":"E Mayola","year":"2011","journal-title":"Apoptosis"},{"key":"ref22","doi-asserted-by":"crossref","first-page":"692","DOI":"10.1016\/j.tiv.2011.01.010","article-title":"Endoplasmic reticulum stress mediates withaferin A induced apoptosis in human renal carcinoma cells","volume":"25","author":"MJ Choi","year":"2011","journal-title":"Toxicol In Vitro"},{"key":"ref23","doi-asserted-by":"crossref","first-page":"1228","DOI":"10.1016\/j.surg.2010.09.026","article-title":"A novel RET inhibitor with potent efficacy against medullary thyroid cancer in vivo","volume":"148","author":"AK Samadi","year":"2010","journal-title":"Surgery"},{"key":"ref24","doi-asserted-by":"crossref","first-page":"1476","DOI":"10.1021\/np100112p","article-title":"Withaferin A, a cytotoxic steroid from Vassobia breviflora, induces apoptosis in human head and neck squamous cell carcinoma","volume":"73","author":"AK Samadi","year":"2010","journal-title":"J Nat Prod"},{"key":"ref25","doi-asserted-by":"crossref","first-page":"1740","DOI":"10.1111\/j.1349-7006.2009.01236.x","article-title":"Effect of the alcoholic extract of Ashwagandha leaves and its components on proliferation, migration, and differentiation of glioblastoma cells: combinational approach for enhanced differentiation","volume":"100","author":"N Shah","year":"2009","journal-title":"Cancer Sci"},{"key":"ref26","doi-asserted-by":"crossref","first-page":"1494","DOI":"10.1007\/s10495-008-0273-y","article-title":"Induction of apoptosis by withaferin A in human leukemia U937 cells through down-regulation of Akt phosphorylation","volume":"13","author":"JH Oh","year":"2008","journal-title":"Apoptosis"},{"key":"ref27","doi-asserted-by":"crossref","first-page":"614","DOI":"10.1016\/j.intimp.2009.02.002","article-title":"Withaferin A inhibits tumor necrosis factor-alpha-induced expression of cell adhesion molecules by inactivation of Akt and NF-kappaB in human pulmonary epithelial cells","volume":"9","author":"JH Oh","year":"2009","journal-title":"Int Immunopharmacol"},{"key":"ref28","doi-asserted-by":"crossref","first-page":"1014","DOI":"10.1007\/s10495-011-0625-x","article-title":"Withaferin A induces apoptosis in human melanoma cells through generation of reactive oxygen species and down-regulation of Bcl-2","volume":"16","author":"E Mayola","year":"2011","journal-title":"Apoptosis"},{"key":"ref29","doi-asserted-by":"crossref","first-page":"1909","DOI":"10.1021\/np400441f","article-title":"Withaferin A, a steroidal lactone from Withania somnifera, induces mitotic catastrophe and growth arrest in prostate cancer cells","volume":"76","author":"RV Roy","year":"2013","journal-title":"J Nat Prod"},{"key":"ref30","doi-asserted-by":"crossref","first-page":"2115","DOI":"10.1007\/s10495-007-0129-x","article-title":"Reactive oxygen species generation and mitochondrial dysfunction in the apoptotic cell death of human myeloid leukemia HL-60 cells by a dietary compound withaferin A with concomitant protection by N-acetyl cysteine","volume":"12","author":"F Malik","year":"2007","journal-title":"Apoptosis"},{"key":"ref31","doi-asserted-by":"crossref","first-page":"1639","DOI":"10.1016\/j.freeradbiomed.2009.03.022","article-title":"Withaferin A sensitizes TRAIL-induced apoptosis through reactive oxygen species-mediated up-regulation of death receptor 5 and downregulation of c-FLIP","volume":"46","author":"TJ Lee","year":"2009","journal-title":"Free Radic Biol Med"},{"key":"ref32","doi-asserted-by":"crossref","first-page":"e23354","DOI":"10.1371\/journal.pone.0023354","article-title":"Withaferin a-induced apoptosis in human breast cancer cells is mediated by reactive oxygen species","volume":"6","author":"ER Hahm","year":"2011","journal-title":"PLoS One"},{"key":"ref33","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1158\/1535-7163.MCT-09-0771","article-title":"Notch-1 inhibition by Withaferin-A: a therapeutic target against colon carcinogenesis","volume":"9","author":"S Koduru","year":"2010","journal-title":"Mol Cancer Ther"},{"key":"ref34","doi-asserted-by":"crossref","first-page":"188","DOI":"10.4161\/cc.7.2.5326","article-title":"Metastatic cancer stem cells: a new target for anti-cancer therapy?","volume":"7","author":"PC Hermann","year":"2008","journal-title":"Cell Cycle"},{"key":"ref35","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1038\/nrc1590","article-title":"Tumour stem cells and drug resistance","volume":"5","author":"M Dean","year":"2005","journal-title":"Nat Rev Cancer"},{"key":"ref36","doi-asserted-by":"crossref","first-page":"730","DOI":"10.1038\/nm0797-730","article-title":"Human acute myeloid leukemia is organized as a hierarchy that originates from a primitive hematopoietic cell","volume":"3","author":"D Bonnet","year":"1997","journal-title":"Nat Med"},{"key":"ref37","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1038\/367645a0","article-title":"A cell initiating human acute myeloid leukemia after transplantation into SCID mice","volume":"367","author":"T Lapidot","year":"1994","journal-title":"Nature"},{"key":"ref38","doi-asserted-by":"crossref","first-page":"3983","DOI":"10.1073\/pnas.0530291100","article-title":"Prospective identification of tumorigenic breast cancer cells","volume":"100","author":"M Al-Hajj","year":"2003","journal-title":"Proc Natl Acad Sci U S A"},{"key":"ref39","doi-asserted-by":"crossref","first-page":"338","DOI":"10.1038\/ncb2717","article-title":"Cancer stem cells: the challenges ahead","volume":"15","author":"JP Medema","year":"2013","journal-title":"Nat Cell Biol"},{"key":"ref40","doi-asserted-by":"crossref","first-page":"e33544","DOI":"10.1371\/journal.pone.0033544","article-title":"A model of cancer stem cells derived from mouse induced pluripotent stem cells","volume":"7","author":"L Chen","year":"2012","journal-title":"PLoS One"},{"key":"ref41","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1038\/nature11344","article-title":"Defining the mode of tumour growth by clonal analysis","volume":"488","author":"G Driessens","year":"2012","journal-title":"Nature"},{"key":"ref42","doi-asserted-by":"crossref","first-page":"730","DOI":"10.1126\/science.1224676","article-title":"Lineage tracing reveals Lgr5+ stem cell activity in mouse intestinal adenomas","volume":"337(6095)","author":"AG Schepers","year":"2012","journal-title":"Science"},{"key":"ref43","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1038\/nature07567","article-title":"Efficient tumour formation by single human melanoma cells","volume":"456","author":"E Quintana","year":"2008","journal-title":"Nature"},{"key":"ref44","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1146\/annurev.med.58.062105.204854","article-title":"Cancer stem cells: models and concepts","volume":"58","author":"P Dalerba","year":"2007","journal-title":"Annu Rev Med"},{"key":"ref45","doi-asserted-by":"crossref","first-page":"3025","DOI":"10.1158\/0008-5472.CAN-04-3931","article-title":"Stem and progenitor-like cells contribute to the aggressive behavior of human epithelial ovarian cancer","volume":"65","author":"SA Bapat","year":"2005","journal-title":"Cancer Res"},{"key":"ref46","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1016\/j.ygyno.2004.12.043","article-title":"Snail and Slug are major determinants of ovarian cancer invasiveness at the transcription level","volume":"97","author":"NK Kurrey","year":"2005","journal-title":"Gyne Oncol"},{"key":"ref47","doi-asserted-by":"crossref","first-page":"4311","DOI":"10.1158\/0008-5472.CAN-08-0364","article-title":"Identification and characterization of ovarian cancer-initiating cells from primary human tumors,","volume":"68","author":"S Zhang","year":"2008","journal-title":"Cancer Res"},{"key":"ref48","doi-asserted-by":"crossref","first-page":"e10277","DOI":"10.1371\/journal.pone.0010277","article-title":"Distinct expression levels and patterns of stem cell marker, aldehyde dehydrogenase isoform 1 (ALDH1), in human epithelial cancers","volume":"5","author":"S Deng","year":"2010","journal-title":"PLoS ONE"},{"key":"ref49","doi-asserted-by":"crossref","first-page":"3991","DOI":"10.1158\/0008-5472.CAN-10-3175","article-title":"Aldehyde dehydrogenase and CD133 define angiogenic ovarian cancer stem cells that portend poor patient survival,","volume":"71","author":"IA Silva","year":"2011","journal-title":"Cancer Res"},{"key":"ref50","doi-asserted-by":"crossref","first-page":"105269","DOI":"10.1155\/2010\/105269","article-title":"Cancer stem cells and epithelial ovarian cancer","volume":"2010","author":"S Dyall","year":"2010","journal-title":"J Oncol"},{"key":"ref51","doi-asserted-by":"crossref","first-page":"158","DOI":"10.4161\/cc.8.1.7533","article-title":"Molecular phenotyping of human ovarian cancer stem cells unravels the mechanisms for repair and chemoresistance","volume":"8","author":"AB Alvero","year":"2009","journal-title":"Cell Cycle"},{"key":"ref52","doi-asserted-by":"crossref","first-page":"9339","DOI":"10.1158\/0008-5472.CAN-06-3126","article-title":"Cancer stem cells\u2013perspectives on current status and future directions: AACR Workshop on cancer stem cells","volume":"66","author":"MF Clarke","year":"2006","journal-title":"Cancer Res"},{"key":"ref53","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1186\/1476-4598-12-24","article-title":"Short-term single treatment of chemotherapy results in the enrichment of ovarian cancer stem cell like cells leading to an increased tumor burden","volume":"12","author":"K Abubaker","year":"2013","journal-title":"Mol Cancer"},{"key":"ref54","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1186\/1476-4598-5-61","article-title":"Regulation of angiogenesis and invasion by human Pituitary tumor transforming gene (PTTG) through increased expression and secretion of matrix metalloproteinase-2 (MMP-2)","volume":"5","author":"MT Malik","year":"2006","journal-title":"Mol Cancer"},{"key":"ref55","first-page":"2146","article-title":"An orthotopic model of serous ovarian cancer in immunocompetent mice for in vivo tumor imaging and monitoring of tumor immune responses","volume":"28.pii","author":"S Nunez-Cruz","year":"2010","journal-title":"J Vis Exp"},{"key":"ref56","doi-asserted-by":"crossref","first-page":"e42265","DOI":"10.1371\/journal.pone.0042265","article-title":"Withaferin A synergizes the therapeutic effect of doxorubicin through ROS-mediated autophagy in ovarian cancer","volume":"7","author":"MY Fong","year":"2012","journal-title":"PLoS One"},{"key":"ref57","doi-asserted-by":"crossref","first-page":"301","DOI":"10.7150\/jca.8610","article-title":"Investigating Molecular Profiles of Ovarian Cancer: An Update on Cancer Stem Cells","volume":"5","author":"F Tomao","year":"2014","journal-title":"J Cancer"},{"key":"ref58","first-page":"189","article-title":"Functional role of solid tumor stem cells in disease etiology and susceptibility to therapeutic interventions","volume":"8","author":"B Ramdass","year":"2013","journal-title":"J Stem Cells"},{"key":"ref59","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1186\/1757-2215-1-4","article-title":"Ovarian cancer: emerging concept on cancer stem cells","volume":"1","author":"MP Ponnusamy","year":"2008","journal-title":"J Ovarian Res"},{"key":"ref60","doi-asserted-by":"crossref","first-page":"2405","DOI":"10.1002\/stem.191","article-title":"Stem like ovarian cancer cells can serve as tumor vascular progenitors","volume":"7","author":"AB Alvero","year":"2009","journal-title":"Stem Cells"},{"key":"ref61","doi-asserted-by":"crossref","first-page":"843","DOI":"10.1038\/nature03319","article-title":"Wnt signaling in stem cells and cancer","volume":"434","author":"T Reya","year":"2005","journal-title":"Nature"},{"key":"ref62","doi-asserted-by":"crossref","first-page":"6063","DOI":"10.1158\/0008-5472.CAN-06-0054","article-title":"Hedgehogsignaling and Bmi-1 regulate self-renewal of normal and malignant human mammary stem cells","volume":"66","author":"S Liu","year":"2006","journal-title":"Cancer Res"},{"key":"ref63","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1186\/bcr920","article-title":"Role of Notch signaling in cell-fate determination of human mammary stem\/progenitor cells,","volume":"6","author":"G Dontu","year":"2004","journal-title":"Breast Cancer Res"},{"key":"ref64","first-page":"1","article-title":"Caught up in a Wnt storm: wnt signaling in cancer,","volume":"1653","author":"RH Giles","year":"2003","journal-title":"Biochim Biophys Acta"},{"key":"ref65","doi-asserted-by":"crossref","first-page":"32","DOI":"10.5306\/wjco.v3.i3.32","article-title":"Novel biomarkers and therapeutic targets for optimizing the therapeutic management of melanomas","volume":"3","author":"M Mimeault","year":"2012","journal-title":"World J Clin Oncol"},{"key":"ref66","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1042\/BSR20100114","article-title":"Epithelial-mesenchymal transition and cancer stemness: the Twist1-Bmi1connection","volume":"31","author":"KJ Wu","year":"2011","journal-title":"Biosci Rep"},{"key":"ref67","doi-asserted-by":"crossref","first-page":"1824","DOI":"10.2741\/3824","article-title":"Breast cancer stem cells: a new challenge for breast cancer treatment","volume":"16","author":"P Jain","year":"2011","journal-title":"Front Biosci"},{"key":"ref68","doi-asserted-by":"crossref","first-page":"2587","DOI":"10.1038\/bjc.2013.642","article-title":"Silencing NOTCH signaling causes growth arrest in both breast cancer stem cells and breast cancer cells","volume":"109","author":"S Suman","year":"2013","journal-title":"Br J Cancer"},{"key":"ref69","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1007\/s10911-006-9011-7","article-title":"Notch signaling in breast cancer and tumor angiogenesis: cross-talk and therapeutic potentials","volume":"11","author":"W Shi","year":"2006","journal-title":"J Mammary Gland Biol Neoplasia"},{"key":"ref70","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1016\/j.clbc.2012.09.017","article-title":"Breast cancer stem cells: a novel therapeutic target","volume":"13","author":"S Gangopadhyay","year":"2013","journal-title":"Clin Breast Cancer"},{"key":"ref71","doi-asserted-by":"crossref","first-page":"1053","DOI":"10.2353\/ajpath.2010.100105","article-title":"Ovarian cancer development and metastasis","volume":"177","author":"E Lengyel","year":"2010","journal-title":"Am J Pathol"},{"key":"ref72","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1007\/BF00689635","article-title":"Signaling and drug sensitivity","volume":"13","author":"RD Christen","year":"1994","journal-title":"Cancer Metastasis Rev"},{"key":"ref73","doi-asserted-by":"crossref","first-page":"678","DOI":"10.1002\/ijc.2910550428","article-title":"Increased accumulation of p53 protein in cisplatin-resistant ovarian cell lines","volume":"55","author":"R Brown","year":"1993","journal-title":"Int J Cancer"},{"key":"ref74","first-page":"556","article-title":"Association between cisplatin resistance and mutation of p53 gene and reduced bax expression in ovarian carcinoma cell systems","volume":"56","author":"P Perego","year":"1996","journal-title":"Cancer Res"},{"key":"ref75","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1007\/s10911-009-9110-3","article-title":"The epithelial-to-mesenchymal transition and cancer stem cells: a coalition against cancer therapies","volume":"14","author":"BG Hollier","year":"2009","journal-title":"J Mammary Gland Biol Neoplasia"},{"key":"ref76","doi-asserted-by":"crossref","first-page":"268","DOI":"10.2174\/156800910791190175","article-title":"Epithelial mesenchymal transition and cancer stem cell-like phenotypes facilitate chemoresistance in recurrent ovarian cancer","volume":"10","author":"N Ahmed","year":"2010","journal-title":"Curr Cancer Drug Targets"},{"key":"ref77","doi-asserted-by":"crossref","first-page":"e46858","DOI":"10.1371\/journal.pone.0046858","article-title":"Isolation and characterization of tumor cells from the ascites of ovarian cancer patients: molecular phenotype of chemoresistant ovarian tumors","volume":"7","author":"A Latifi","year":"2012","journal-title":"PLoS One"},{"key":"ref78","doi-asserted-by":"crossref","first-page":"2672","DOI":"10.1038\/onc.2010.35","article-title":"CD24+ cells from hierarchically organized ovarian cancer are enriched in cancer stem cells","volume":"29","author":"MQ Gao","year":"2010","journal-title":"Oncogene"},{"key":"ref79","doi-asserted-by":"crossref","first-page":"3186","DOI":"10.1158\/1535-7163.MCT-10-0563","article-title":"Targeting aldehyde dehydrogenase cancer stem cells in ovarian cancer","volume":"9","author":"CN Landen Jr","year":"2010","journal-title":"Mol Cancer Ther"},{"key":"ref80","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1186\/1746-1596-7-44","article-title":"Expression features of SOX9 associate with tumor progression and poor prognosis of hepatocellular carcinoma","volume":"7","author":"X Guo","year":"2012","journal-title":"Diagn Pathol"},{"key":"ref81","first-page":"4943","article-title":"CD46 expression is indicative of shorter revival-free survival for ovarian cancer patients","volume":"26","author":"P Surowiak","year":"2006","journal-title":"Anticancer Res"},{"key":"ref82","doi-asserted-by":"crossref","first-page":"855","DOI":"10.1177\/0961203310394895","article-title":"Precuneus hypoperfusion plays an important role in memory impairment of patients with systemic lupus erythematosus","volume":"20","author":"DH Oh","year":"2011","journal-title":"Lupus"},{"key":"ref83","doi-asserted-by":"crossref","first-page":"869","DOI":"10.1158\/1078-0432.CCR-11-2188","article-title":"Stem cell pathways contribute to clinical chemoresistance in ovarian cancer","volume":"18","author":"AD Steg","year":"2012","journal-title":"Clin Cancer Res"},{"key":"ref84","doi-asserted-by":"crossref","first-page":"11154","DOI":"10.1073\/pnas.0603672103","article-title":"Ovarian cancer side population defines cells with stem cell-like characteristics and Mullerian Inhibiting Substance responsiveness","volume":"103","author":"PP Szotek","year":"2006","journal-title":"Proc Natl Acad Sci U S A"},{"key":"ref85","doi-asserted-by":"crossref","first-page":"e29079","DOI":"10.1371\/journal.pone.0029079","article-title":"Identification of a potential ovarian cancer stem cell gene expression profile from advanced stage papillary serous ovarian cancer","volume":"7","author":"V Vathipadiekal","year":"2012","journal-title":"PLoS One"},{"key":"ref86","doi-asserted-by":"crossref","first-page":"6624","DOI":"10.3390\/ijms14046624","article-title":"Regulation of ovarian cancer stem cells or tumor-initiating cells","volume":"14","author":"MJ Kwon","year":"2013","journal-title":"Int J Mol Sci"}],"container-title":["PLoS ONE"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/dx.plos.org\/10.1371\/journal.pone.0107596","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,8,15]],"date-time":"2019-08-15T15:23:26Z","timestamp":1565882606000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0107596"}},"subtitle":[],"editor":[{"given":"Deodutta","family":"Roy","sequence":"first","affiliation":[],"role":[{"role":"editor","vocabulary":"crossref"}]}],"short-title":[],"issued":{"date-parts":[[2014,9,29]]},"references-count":86,"journal-issue":{"issue":"9","published-online":{"date-parts":[[2014,9,29]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0107596","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2014,9,29]]}}}